A Proprietor's 'Best Seller' with a Borrowed NAFDAC Number
You are the superintendent pharmacist of a community pharmacy in Owerri. The proprietor returns from a trade fair with 40 cartons of a herbal capsule marketed as 'Sugar-Free Forever' for diabetes. Each carton holds 24 packs of 30 capsules. The label claims the product 'reduces blood sugar within 7 days' and bears a NAFDAC registration number that does not match the number on NAFDAC's public register; the number belongs to a registered cosmetic cream. The wholesale price was ₦180,000 per carton, and the proprietor has already paid. He wants the product displayed at the front counter with a 'buy two, get one free' promotion because a nearby pharmacy sells a similar brand. Two patients with type 2 diabetes have already asked about it. The pharmacy licence is due for renewal in three months, and a PCN inspector is scheduled for a routine visit. The proprietor tells you that 'everybody sells it' and that refusing will cost the business. Describe your position and actions.
1. May the pharmacy legally stock, display, or sell this product? Identify the regulatory and ethical issues and state your decision.
Read the worked answer
Decision: No. The product must not be stocked for sale, displayed, promoted, or dispensed.
- The label makes a therapeutic claim ('reduces blood sugar within 7 days'). That takes the product beyond a cosmetic or ordinary food supplement and into the category of a drug/medicinal product, which requires valid NAFDAC registration before sale.
- The registration number belongs to a different product. A borrowed or fabricated number is not a minor labelling defect; it indicates an unregistered product and possible counterfeit/substandard status.
- Selling an unregistered medicine is an offence under Nigeria's medicines regulatory framework, and the superintendent pharmacist is personally and professionally accountable. The proprietor's commercial argument does not transfer the legal risk away from the pharmacist.
- The PCN Code of Ethics requires the pharmacist to obey the law, protect public safety, and avoid professional misconduct. Assisting a promotion that encourages diabetic patients to replace or delay proven treatment is also an ethical breach.
- The pending licence renewal and inspection increase the urgency: concealment would worsen the position.
Therefore, the correct professional response is refusal, quarantine of the stock, and notification, not a quiet compromise.
2. Set out your immediate practical steps in the pharmacy, including what you would say to the proprietor and which external bodies you would notify.
Read the worked answer
Immediate steps
- Quarantine all 40 cartons in a locked room or cabinet. Label them 'DO NOT SELL - unregistered product - pending regulatory action'. Do not put them behind the counter or in the shop window.
- Record the facts: product name, batch number, expiry date, quantity, supplier, invoice number, the NAFDAC number printed, and the date received. Keep the invoice and any promotional material.
- Check other stock for the same product or same supplier. If found, quarantine those as well and record the quantity.
- Inform the proprietor in writing that the product cannot be sold because the registration number does not match the product and because therapeutic claims require valid registration. State that you will not authorise sale or promotion and that staff have been instructed not to dispense it.
- Notify NAFDAC of the product and the false registration number, and notify PCN in writing as the superintendent pharmacist. Ask for guidance on secure return or destruction; do not return stock to a supplier for resale.
- Brief all staff that the product is not to be sold, and keep a written record of that briefing.
- If the proprietor insists, refuse to sign off the stock, document the instruction and your objection, and consider escalating within the company or withdrawing from the arrangement. Financial loss is not a defence for dispensing an unregistered medicine.
3. Two patients with diabetes ask whether they should buy the product. What would you tell them, and what would you document?
Read the worked answer
Counselling message
- Tell them clearly that you cannot recommend the product. It is not registered for sale in Nigeria as labelled, and its claim to lower blood sugar within 7 days is not supported by the registration details on the pack.
- Ask what medicines they currently take for diabetes, whether they have a glucometer, and what their recent readings have been. Emphasise that they should not stop or reduce metformin, insulin, or any prescribed medicine.
- Explain that uncontrolled diabetes can cause silent damage to the kidneys, eyes, nerves, and blood vessels, so the safe course is to continue prescribed treatment and see their clinician for review.
- Advise them to bring the product or a photograph of it to their doctor if they have already bought it, and to report any unusual symptoms to you or the prescriber.
- Do not create unnecessary alarm, but do not soften the regulatory facts.
Documentation
Record the date, the patients' names or identifiers, the advice given, the products they are taking, and any referral made. Keep a separate log of inquiries about the product. This protects the patients and demonstrates that the pharmacy acted professionally.